Inventor · disambiguated record
Henrik Frydenlund Hansen
Also filed as: HANSEN HENRIK · HANSEN HENRIK F · HANSEN HENRIK FRYDENLUND
34 granted patents·20 pending applications·769 citations·filing 1987–2022
97Inventor score
Files withROCHE INNOVATION CT COPENHAGEN AS21SANTARIS PHARMA AS8BOSTON SCIENT SCIMED INC2CHRISTENSEN LEIF2HANSEN HENRIK FRYDENLUND2
Top patents by PatentIndex Score
54 records- 0198US7589190B2Potent LNA oligonucleotides for the inhibition of HIF-1A expressionSANTARIS PHARMA AS·Filed 2005·Granted Sep 15, 2009·129 cites·8 claims
- 0297US9708614B2Antisense designROCHE INNOVATION CT COPENHAGEN AS·Filed 2016·Granted Jul 18, 2017·28 cites·36 claims
- 0397US9428534B2Antisense designSANTARIS PHARMA AS·Filed 2013·Granted Aug 30, 2016·46 cites·78 claims
- 0497US7687617B2Oligonucleotides with alternating segments of locked and non-locked nucleotidesSANTARIS PHARMA AS·Filed 2003·Granted Mar 30, 2010·207 cites·26 claims
- 0593US8580756B2Short oligomer antagonist compounds for the modulation of target mRNAHANSEN JENS BO RODE·Filed 2008·Granted Nov 12, 2013·52 cites·17 claims
- 0692US9994850B2Antisense designROCHE INNOVATION CT COPENHAGEN AS·Filed 2017·Granted Jun 12, 2018·4 cites·19 claims
- 0789US9045518B2Amino-LNA, thio-LNA and alpha-L-oxy-LNCHRISTENSEN SIGNE M·Filed 2003·Granted Jun 2, 2015·19 cites·19 claims
- 0887US10077443B2Oligonucleotide conjugatesROCHE INNOVATION CT COPENHAGEN AS·Filed 2013·Granted Sep 18, 2018·10 cites·22 claims
- 0986US6225052B1Method for determining a nucleic acidROCHE DIAGNOSTICS GMBH·Filed 1997·Granted May 1, 2001·101 cites·19 claims
- 1085US10358643B2Poly oligomer compound with biocleavable conjugatesHOFFMANN LA ROCHE·Filed 2015·Granted Jul 23, 2019·7 cites·18 claims
- 1178US7939507B2Potent LNA oligonucleotides for the inhibition of HIF-1a expressionENZON PHARMACEUTICALS INC·Filed 2009·Granted May 10, 2011·2 cites·5 claims
- 1276US6310179B12-or 3-dimensional geometric structuresDAKO AS·Filed 1998·Granted Oct 30, 2001·24 cites·9 claims
- 1375US9447138B2Potent LNA oligonucleotides for the inhibition of HIF-1a expressionSANTARIS PHARMA AS·Filed 2013·Granted Sep 20, 2016·1 cites·4 claims
- 1475US8470791B2RNA antagonist compounds for the inhibition of Apo-B100 expressionHANSEN HENRIK FRYDENLUND·Filed 2008·Granted Jun 25, 2013·3 cites·28 claims
- 1574US6548651B1Modified peptide nucleic acid (PNA) moleculesPANTHECO AS·Filed 2000·Granted Apr 15, 2003·37 cites·1 claims
- 1673US6117973APNA monomers with electron donor or acceptorGEORGIA TECH RES INST·Filed 1997·Granted Sep 12, 2000·45 cites·9 claims
- 1772US2018237777A1Antisense designROCHE INNOVATION CT COPENHAGEN AS·Filed 2018·Application pending·0 cites
- 1871US9951333B2Antisense designROCHE INNOVATION CT COPENHAGEN AS·Filed 2017·Granted Apr 24, 2018·0 cites·30 claims
- 1971US9890383B2Antisense designROCHE INNOVATION CT COPENHAGEN AS·Filed 2017·Granted Feb 13, 2018·0 cites·30 claims
- 2070US2014128591A1Antisense designSANTARIS PHARMA AS·Filed 2013·Application pending·0 cites
- 2170US2018237778A1Antisense designROCHE INNOVATION CT COPENHAGEN AS·Filed 2018·Application pending·0 cites
- 2268US6858726B2Synthesis of allofuranoseSANTARIS PHARMA AS·Filed 2002·Granted Feb 22, 2005·2 cites·16 claims
- 2368US2021238601A1Oligonucleotide ConjugatesROCHE INNOVATION CT COPENHAGEN AS·Filed 2021·Application pending·0 cites
- 2468US2014194614A1Amino-lna, thio-lna and alpha-l-oxy-lnSANTARIS PHARMA AS·Filed 2013·Application pending·0 cites
- 2566US11155816B2Oligonucleotide conjugatesROCHE INNOVATION CT COPENHAGEN AS·Filed 2018·Granted Oct 26, 2021·0 cites·24 claims
- 2666US2014128586A1Amino-lna, thio-lna and alpha-l-oxy-lnSANTARIS PHARMA AS·Filed 2013·Application pending·0 cites
- 2766US2016168575A1Antisense designROCHE INNOVATION CT COPENHAGEN AS·Filed 2015·Application pending·0 cites
- 2865US9364495B2Oral delivery of therapeutically effective LNA oligonucleotidesHARDEE GREGROY·Filed 2010·Granted Jun 14, 2016·2 cites·17 claims
- 2965US8410071B2Potent LNA oligonucleotides for the inhibition of HIF-1A expressionWESTERGAARD MAJKEN·Filed 2011·Granted Apr 2, 2013·1 cites·9 claims
- 3065US2016168576A1Antisense designROCHE INNOVATION CT COPENHAGEN AS·Filed 2015·Application pending·0 cites
- 3162US2023002762A1Oligonucleotides comprising a phosphorodithioate internucleoside linkageROCHE INNOVATION CT COPENHAGEN AS·Filed 2022·Application pending·0 cites
- 3260US9938527B2Potent LNA oligonucleotides for the inhibition of HIF-1A expressionROCHE INNOVATION CT COPENHAGEN AS·Filed 2016·Granted Apr 10, 2018·0 cites·12 claims
- 3360US6020132AMethod of analysis using signal amplificationROCHE DIAGNOSTICS GMBH·Filed 1997·Granted Feb 1, 2000·26 cites·23 claims
- 3454US6521744B12- or 3-dimensional geometric structuresPNA DIAGNOSTICS AS·Filed 2000·Granted Feb 18, 2003·0 cites·9 claims
- 3554US2020318103A1Stereodefined sub-motif optimisation methodsROCHE INNOVATION CT COPENHAGEN AS·Filed 2020·Application pending·0 cites
- 3653US2020339982A1Oligonucleotides comprising a phosphorodithioate internucleoside linkageROCHE INNOVATION CT COPENHAGEN AS·Filed 2018·Application pending·0 cites
- 3750US7758605B2Balloon folding apparatus, methods and productsBOSTON SCIENT SCIMED INC·Filed 2004·Granted Jul 20, 2010·7 cites·55 claims
- 3850US2020332289A1Gapmer oligonucleotides comprising a phosphorodithioate internucleoside linkageROCHE INNOVATION CT COPENHAGEN AS·Filed 2018·Application pending·0 cites
- 3950US2016289677A1APOB Antisense Conjugate CompoundsROCHE INNOVATION CT COPENHAGEN AS·Filed 2014·Application pending·0 cites
- 4049US5315016AProcess for preparing pure podophyllotoxinNYCOMED DAK AS·Filed 1992·Granted May 24, 1994·6 cites·52 claims
- 4149US2018016575A1LNA Gapmer Oligonucleotides Comprising Chiral Phosphorothioate LinkagesROCHE INNOVATION CT COPENHAGEN AS·Filed 2015·Application pending·0 cites
- 4249US2018112217A1Stereospecific Phosphorothioate LNAROCHE INNOVATION CT COPENHAGEN AS·Filed 2015·Application pending·0 cites
- 4347US7951164B2Balloon folding apparatus, methods and productsBOSTON SCIENT SCIMED INC·Filed 2002·Granted May 31, 2011·2 cites·15 claims
- 4444US8568437B2Balloon folding apparatus, methods and productsMCMORROW DAVID·Filed 2011·Granted Oct 29, 2013·0 cites·10 claims
- 4544US7825215B1Substituted nucleic acid mimicsCHRISTENSEN LEIF·Filed 1996·Granted Nov 2, 2010·4 cites·11 claims
- 4644US2009176977A1Lna modified phosphorothiolated oligonucleotidesELMEN JOACIM·Filed 2007·Application pending·0 cites
- 4743US7569659B1Admixture comprising a target molecule and a nucleic acid mimic comprising sterically bulky substituentsCHRISTENSEN LEIF·Filed 1997·Granted Aug 4, 2009·4 cites·11 claims
- 4842US2015368642A1Lna oligonucleotide carbohydrate conjugatesHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 4942US2003199431A1Modified peptide nucleic acid (PNA) moleculesFiled 2002·Application pending·0 cites
- 5042US2003176325A1Modified peptide nucleic acid (PNA) moleculesPANTHECO AS AND PETER E NIELSE·Filed 2001·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →